PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
19.28%
Revenue growth of 19.28% while AVGO is flat. Bruce Berkowitz would check if a small edge can widen further.
21.59%
Gross profit growth of 21.59% while AVGO is zero. Bruce Berkowitz would see if minimal improvements could expand further.
34.14%
EBIT growth of 34.14% while AVGO is zero. Bruce Berkowitz would see if small gains can be scaled further.
34.14%
Operating income growth of 34.14% while AVGO is zero. Bruce Berkowitz would see if this modest edge can become significant.
36.43%
Net income growth of 36.43% while AVGO is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
41.03%
EPS growth of 41.03% while AVGO is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
31.94%
Diluted EPS growth of 31.94% while AVGO is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
1.40%
Share change of 1.40% while AVGO is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
1.52%
Diluted share change of 1.52% while AVGO is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
14.80%
OCF growth of 14.80% while AVGO is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
9.76%
FCF growth of 9.76% while AVGO is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
631.87%
10Y CAGR of 631.87% while AVGO is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
114.89%
5Y CAGR of 114.89% while AVGO is zero. Bruce Berkowitz would see if small improvements can scale into a larger advantage.
94.21%
3Y CAGR of 94.21% while AVGO is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
2203.77%
OCF/share CAGR of 2203.77% while AVGO is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
245.23%
OCF/share CAGR of 245.23% while AVGO is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
78514.32%
3Y OCF/share CAGR of 78514.32% while AVGO is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
1314.76%
10Y net income/share CAGR of 1314.76% while AVGO is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
501.62%
Net income/share CAGR of 501.62% while AVGO is zero. Bruce Berkowitz would see if small mid-term gains can develop into a bigger lead.
717.34%
3Y net income/share CAGR of 717.34% while AVGO is zero. Bruce Berkowitz sees if minor improvements can widen to a bigger advantage.
1502.49%
Equity/share CAGR of 1502.49% while AVGO is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
133.59%
Equity/share CAGR of 133.59% while AVGO is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
100.66%
Equity/share CAGR of 100.66% while AVGO is zero. Bruce Berkowitz sees if minor gains can snowball into a bigger lead soon.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.65%
AR growth of 8.65% while AVGO is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
10.80%
Inventory growth of 10.80% while AVGO is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
14.46%
Asset growth of 14.46% while AVGO is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
8.12%
BV/share growth of 8.12% while AVGO is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
13.66%
R&D growth of 13.66% while AVGO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
8.49%
SG&A growth of 8.49% while AVGO is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.